FOLH1 and metastatic malignant neoplasm in the lymph nodes: The clinical PET/CT images obtained with 152Tb-PSMA-617 in a patient with metastatic prostate cancer were of diagnostic quality, enabling the visualization of all target lesions previously detected with 68Ga-PSMA-11, including the clear identification of specific radioligand uptake in bone and lymph node metastases as well as in recurrent disease in the seminal vesicles.